Clinical Trial Update: Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Q8003 to its individual components in bunionectomy patients assessed efficacy and safety for postoperative pain and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Q8003

Snippet

Sponsor: QRxPharma Inc. | Conditions: Postoperative Pain | Phase 2 | Status: COMPLETED